Mango Juice for Prediabetes
(MG4 Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
The purpose of this study is to determine whether daily mango consumption for 6 weeks can improve glucose utilization in individuals with prediabetes. The findings from this research may help explore the potential role of mangoes in a healthy diet for people at risk of developing type 2 diabetes
Who Is on the Research Team?
Britt Burton-Freeman, PhD
Principal Investigator
Illinois Institute of Technology
Amandeep Sandhu, PhD
Principal Investigator
Illinois Institute of Technology
Are You a Good Fit for This Trial?
This trial is for adults who have prediabetes or trouble processing glucose but do not yet have diabetes. Participants should generally be in stable health and able to follow the study instructions.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants consume a mango or control beverage daily for 6 weeks, with continuous glucose monitoring and dietary assessments
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Trial Overview
The study compares daily mango juice with a control beverage over 6 weeks to see if mango can help people with prediabetes use sugar more effectively. Participants are randomly assigned to one of the two groups.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Placebo Group
1 cup (165 grams) of mango smoothie twice a day.
calorie-matched control intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Clinical Nutrition Research Center, Illinois Institute of Technology
Lead Sponsor
National Mango Board
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.